European Heart Journal Advance Access originally published online on October 4, 2005
European Heart Journal 2005 26(24):2644-2649; doi:10.1093/eurheartj/ehi502
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study
1Department of Cardiology 8K12 IE, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium
2Department of Public Health, Ghent University, Belgium
3Department of Clinical Biology, Ghent University, Belgium
4School of Public Health, Université Libre de Bruxelles, Belgium
Received 7 March 2005; revised 24 August 2005; accepted 2 September 2005; online publish-ahead-of-print 4 October 2005.
* Corresponding author. Tel: +32 9 240 34 76; fax: +32 9 240 58 26. E-mail address: johan.desutter{at}ugent.be
See page 2603 for the editorial comment on this article (doi:10.1093/eurheartj/ehi614)
Aims Increased levels of neurohormonal markers, including the N-terminal fragment of pro-brain natriuretic peptide (NT-pro-BNP), have been shown to be of prognostic significance in patients with heart failure or coronary heart disease (CHD). The aim of this study was to study the predictive value of NT-pro-BNP for coronary events in a middle-aged population of men at work.
Methods and results A nested case–control study was performed in a large cohort of over 10 000 men at work (aged 35–59) after a median follow-up of 2.66 years. In total, 66 individuals who developed coronary events were matched on a 3-to-1 basis to 198 controls free of coronary events during follow-up. Besides clinical characteristics and conventional cardiac risk factors, NT-pro-BNP (electrochemiluminiscence assay, Roche diagnostics) and serum creatinine levels were determined. In univariable analysis, cases were more frequently current smokers and diabetics, had more frequently a history of CHD, and had higher levels of total cholesterol and systolic blood pressure (SBP), and lower levels of HDL cholesterol. A highly significant difference (P<0.0001) was noted for NT-pro-BNP levels between cases (median 48.5 pg/mL, interquartile range 26.4–116.6 pg/mL) and controls (30.0 pg/mL, 19.5–47.6 pg/mL). In multivariable conditional logistic regression analysis, NT-pro-BNP remained strongly associated with risk for coronary events [third vs. first tertile, odds ratio (95% CI) 3.24 (1.18–8.85)], independent of body mass index, smoking, diabetes, SBP, total and HDL cholesterol, creatinine, and previous CHD.
Conclusion NT-pro-BNP is a strong predictor of coronary events in men at work after a relatively short period, even after adjustment for conventional risk factors.
Key Words: Natriuretic peptide • Cardiac risk factors • Cardiac events • General population
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Coronary artery disease, heart failure, and cardiac natriuretic peptides in the middle
- Jens Peter Goetze
EHJ 2005 26: 2603-2604.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  K. Brune, H. A. Katus, J. Moecks, E. Spanuth, A. S. Jaffe, and E. Giannitsis N-Terminal Pro-B-Type Natriuretic Peptide Concentrations Predict the Risk of Cardiovascular Adverse Events from Antiinflammatory Drugs: A Pilot Trial Clin. Chem., July 1, 2008; 54(7): 1149 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Goetze Coronary artery disease, heart failure, and cardiac natriuretic peptides in the middle Eur. Heart J., December 2, 2005; 26(24): 2603 - 2604. [Full Text] [PDF]
|
|